InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the detailed record of transactions filed by Krognes Steve E., Chief Financial Officer. Insider active across 1 companies, notably Denali Therapeutics Inc.. In total, 9 disclosures have been recorded. Total volume traded: €515k. The latest transaction was disclosed on 11 February 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€77,7942,560 shares@ €30.38840.0030% mcap15.1% of flow
Common Stock
SEC:0001714899-22-000041:0·
€42,0901,296 shares@ €32.47720.0016% mcap19.2% of flow
Common Stock
SEC:0001714899-22-000036·
€42,0901,296 shares@ €32.47720.0016% mcap8.2% of flow
Common Stock
SEC:0001714899-22-000036:0·
€88,2422,225 shares@ €39.65920.0034% mcap40.3% of flow
Common Stock
SEC:0001714899-22-000007·
€88,2422,225 shares@ €39.65920.0034% mcap17.1% of flow
Common Stock
SEC:0001714899-22-000007:0·
031,000 shares0
Common Stock
SEC:0001714899-22-000001·
031,000 shares0
Common Stock
SEC:0001714899-22-000001:0·
€88,4242,085 shares@ €42.40960.0034% mcap40.4% of flow
Common Stock
SEC:0001714899-21-000084·
€88,4242,085 shares@ €42.40960.0034% mcap17.2% of flow
Common Stock
SEC:0001714899-21-000084:0·
9 of 9 declarations
About Krognes Steve E.
Steve E. Krognes is the Chief Financial Officer and Treasurer of Denali Therapeutics Inc. He is responsible for the company's financial management, including financial planning, risk management, and investor relations. With a strong background in the industry, he plays a key role in the strategic direction of the company and maximizing shareholder value.
